Clinical Trial Update: DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating depot medroxyprogesterone acetate (DMPA) and high-dose oral medroxyprogesterone acetate (MPA) for outpatient treatment of dysfunctional…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysfunctional Uterine Bleeding

Drugs mentioned

• Depo-Provera (medroxyprogesterone acetate)
• Provera (medroxyprogesterone acetate)

Snippet

Sponsor: Women's Health Care Clinic, Torrance, California | Conditions: Dysfunctional Uterine Bleeding | Phase 4 | Status: COMPLETED | Results posted: 2014-02-11